| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thrombosis |
From AstraZeneca R&D Mölndal (J.-A.B.), Mölndal; The Cardiovascular Institute (J.-A.B., S.J., C.J.), Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Östra, Göteborg University; and Institute of Clinical Neuroscience (C.J.), Sahlgrenska University Hospital/Sahlgrenska, Göteborg University, Sweden.
Correspondence to Christina Jern, MD, PhD, Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Östra, Göteborg University, S-416 85 Göteborg, Sweden. E-mail christina.jern{at}neuro.gu.se
Objective This study was undertaken to determine whether stimulation of sympathetic cardiac nerves induces release of the thrombolytic enzyme tissue-type plasminogen activator (t-PA) in the coronary vascular bed.
Methods and Results Anesthetized pigs were studied in an open chest model. Bilateral vagotomy was performed, and sympathetic cardiac nerves were activated by electrical stimulation (1 and 8 Hz). To evaluate possible mediating effects of increased heart rate and enhanced local blood flow, tachycardia was induced by pacing and hyperemia by local infusion of sodium nitroprusside and clevedipine. Furthermore, to study the effects of
- and ß-adrenergic receptor stimulation, phenylephrine and isoprenaline were infused locally. In response to low- and high-frequency sympathetic stimulation, mean coronary net release of total t-PA increased approximately 6- and 25-fold, respectively. Active t-PA showed a similar response pattern. Neither tachycardia nor coronary hyperemia stimulated t-PA release. In contrast, ß-adrenergic stimulation by isoprenaline induced an approximately 6-fold increase in coronary t-PA release, whereas no significant change in release rates occurred in response to
-adrenergic stimulation by phenylephrine.
Conclusions Stimulation of cardiac sympathetic nerves induces a marked coronary release of t-PA, and part of this response may be mediated through stimulation of ß-adrenergic receptors.
Key Words: tissue-type plasminogen activator sympathetic nerves adrenergic coronary pigs
This article has been cited by other articles:
![]() |
U. Schaefer, S. Vorlova, T. Machida, J. P. Melchor, S. Strickland, and R. Levi Modulation of Sympathetic Activity by Tissue Plasminogen Activator Is Independent of Plasminogen and Urokinase J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schaefer, T. Machida, S. Vorlova, S. Strickland, and R. Levi The plasminogen activator system modulates sympathetic nerve function J. Exp. Med., September 4, 2006; 203(9): 2191 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hao, C. Guo, X. Jiang, S. Krueger, T. Pietri, S. Dufour, R. E. Cone, and J. O'Rourke New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls Blood, July 1, 2006; 108(1): 200 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ridderstrale, E. Ulfhammer, S. Jern, and T. Hrafnkelsdottir Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy Hypertension, April 1, 2006; 47(4): 686 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Oliver, D. J. Webb, and D. E. Newby Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2470 - 2479. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |